We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DLHC:NASDAQDLH Holdings Corp. Analysis

Data as of 2026-03-29 - not real-time

$5.59

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

DLH Holdings Corp. is trading at $5.59, just above the calculated support of $5.50 and well below its book value of $7.74, yielding a low price‑to‑book of 0.72 and a price‑to‑sales of 0.25. The company’s revenue fell 24% YoY to $322.6 M and it posted a negative trailing EPS of –$0.08, while operating cash flow remains positive at $29.9 M. Despite these fundamentals, the DCF model implies a fair value of $20.74, suggesting roughly 79% upside, and the technicals show a bullish SMA alignment (20‑day SMA above 50‑day and 200‑day SMAs) with a rising volume trend. However, the MACD is bearish (negative line, histogram below zero) and the RSI sits at 44.5, indicating neutral momentum, and the 30‑day volatility is high at 46.8%.
The balance sheet is strained: cash of $0.26 M versus debt of $149.8 M creates a debt‑to‑equity of 133.5, and the forward PE is –19.96, reflecting earnings weakness. The stock has a single analyst target of $10 and a “Greed” market sentiment (Fear & Greed Index 65.9). High volatility, a sizable max drawdown of –34.8%, and limited liquidity (average volume ~10k) add to the risk profile, while the company’s federal‑contract focus introduces moderate regulatory exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Price flirting with support at $5.50
  • Bearish MACD signal
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Significant upside potential from DCF valuation
  • Improving operating cash flow but persistent earnings loss
  • High debt load limiting financial flexibility

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Substantial valuation gap versus book value and DCF estimate
  • Strategic federal contract exposure offering stable revenue base
  • Potential for turnaround if cost discipline and revenue growth materialize

Key Metrics & Analysis

Financial Health

Revenue Growth-24.10%
Profit Margin-0.33%
P/E Ratio-20.0
ROE-0.96%
ROA2.58%
Debt/Equity133.53
P/B Ratio0.7
Op. Cash Flow$30.0M
Free Cash Flow$33.9M
Industry P/E28.1

Technical Analysis

TrendBullish
RSI44.5
Support$5.50
Resistance$6.25
MA 20$5.82
MA 50$5.80
MA 200$5.73
MACDBearish
VolumeIncreasing
Fear & Greed Index65.98

Valuation

Fair Value$20.74
Target Price$10.00
Upside/Downside78.89%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.67
Volatility46.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.